Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
Biovator Attracts New Investment Partner
March 21st, 2008
In less than a year, animal allergenicity testing for the production of cosmetics in the European Union will be banned, leaving only a limited time to find alternative methods to avoid further exemptions. Biovator, a Sweden-based biotech company, is developing a solution to part of the problem with its test tube based technology - the in Vitro CPA test. Government investment agency, ALMI Foretagspartner AB, in conjunction with owners LinkMed, has decided to provide funding to further develop the procedure, which uses human tissue to identify substances that cause allergic reactions. Biovator has come a long way in refining the technology, which could replace some of the...
Source: Health Business Week (2008-03-21)
|
